Evidence map›Paper›PMID 34545754›Full record

ArticleFuture medicinal chemistry2021

Application of iron oxide nanoparticles to control the release of minocycline for the treatment of glioblastoma.

Marco A Arriaga, Dean Michael Enriquez, Arely D Salinas, Romeo Garcia, Carlos Trevino De Leo, Silverio A Lopez, Karen S Martirosyan, Sue Anne Chew

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future medicinal chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Neurosurgical Applications of Magnetic Hyperthermia Therapy.Neurosurgery clinics of North America · 2023
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marco A ArriagaDepartment of Health & Biomedical Sciences, University of Texas Rio Grande Valley, Brownsville, TX 78520, USA.ORCID 0000-0003-3868-560X
Dean Michael EnriquezDepartment of Health & Biomedical Sciences, University of Texas Rio Grande Valley, Brownsville, TX 78520, USA.
Arely D SalinasDepartment of Health & Biomedical Sciences, University of Texas Rio Grande Valley, Brownsville, TX 78520, USA.
Romeo GarciaDepartment of Health & Biomedical Sciences, University of Texas Rio Grande Valley, Brownsville, TX 78520, USA.
Carlos Trevino De LeoDepartment of Physics & Astronomy, University of Texas Rio Grande Valley, Brownsville, TX 78520, USA.
Silverio A LopezDepartment of Physics & Astronomy, University of Texas Rio Grande Valley, Brownsville, TX 78520, USA.
Karen S MartirosyanDepartment of Physics & Astronomy, University of Texas Rio Grande Valley, Brownsville, TX 78520, USA.
Sue Anne ChewDepartment of Health & Biomedical Sciences, University of Texas Rio Grande Valley, Brownsville, TX 78520, USA.
The University of Texas Rio Grande Valley · US

Funding

Local dual delivery of a chemotherapy and an anti-angiogenic agent from an injectable functionalized biodegradable biomaterial system for the treatment of gliomasSC3GM135138 · NIGMS · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI CHEW, SUE ANNE · 2020 to 2023
$436k
NIGMS NIH HHS SC3 GM135138
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsCell Line, TumorCell ProliferationCell SurvivalDrug LiberationDrug Screening Assays, AntitumorGlioblastomaHumansMagnetic Iron Oxide NanoparticlesMinocyclineAntineoplastic AgentsMinocyclinedrug deliveryhyperthermiairon oxide nanoparticlesminocyclinePLGA scaffolds

Identifiers

PMID34545754
PMCPMC8525315
OpenAlexW3200579785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.